Amongst sufferers with relapsed/refractory follicular lymphoma, fixed-duration Epkinly (epcoritamab) plus Rituxan (rituximab) and Revlimid (lenalidomide; R2) was related to important enhancements in...
Amongst match sufferers with acute myeloid leukemia, the mix of azacitidine plus Venclexta (venetoclax) was related to a considerably improved event-free survival...
Amongst sufferers with acute myeloid leukemia, Black race has been discovered to be an impartial prognostic issue for decrease survival outcomes, no...
Amongst sufferers experiencing persistent graft-versus-host illness (cGVHD), the transition of remedy with Niktimvo (axatilimab) to a dose of 0.6 milligrams per kilogram...
